RxDoctor Payments Data

Thomas Ross

Family Medicine · Des Moines, IANPI 1114997731

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $165,711 of the $169,928 with a category attached, or 97.5%. Organon accounts for 82.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $60,798 and has fallen 76.8% since, to $14,102 in 2025. Among family medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$169,928in general payments, 2019–2025

Across 203 payments — averaging $837.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$139K
  • Merck$30K
  • AstraZeneca$39

What the payments were for

  • Speaking & faculty fees$165,71198%
  • Travel & lodging$3,8732%
  • Food & beverage$3450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organon145$139,394
Merck57$30,495
AstraZeneca1$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$169,928 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Other family medicine in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →